Basilea Pharmaceutica (BSLN.SW) Reports Presentation of 19 Posters at ICAAC on Investigational Anti-Infectives Isavuconazole, Ceftobiprole, and BAL30072
9/13/2013 9:21:54 AM
Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that 19 posters are being presented on the anti-infectives isavuconazole, ceftobiprole, and BAL30072 at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The conference is taking place from September 10 to 13, 2013 in Denver, USA.
Help employers find you! Check out all the jobs and post your resume.
comments powered by